Preventix: Funding, Investors & Team (Nov 2026)
Preventix, created by the Mexican research laboratory Timser, is a novel screening test that uses a minimally invasive approach to detect cervical cancer early on. Rather than collecting cervical cells like the Pap smear, Preventix looks for certain biomarkers in the blood that signal inflammation or abnormalities in the cervix. By analyzing a comprehensive 53-element blood chemistry panel, the test can identify signs of inflammation or potential precancerous developments.
Preventix has raised $3.5M across 1 funding round on record, the most recent a Seed of $3.5M announced in May 2025.
That round is below the $8.9M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Preventix Company Profile and Key Stats
Latest funding round on record: May 2025.
Preventix Funding Rounds
Preventix Founders and Leadership Team
No contact details are on record for this team yet.
Preventix Funding Compared to Other Biotechnology Startups
Preventix's latest round of $3.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Preventix in Biotechnology and Torres
Companies Similar to Preventix
Austria's YGION Biomedical is dedicated to turning personalized cancer immunotherapy into a viable option.
Orakl Oncology is dedicated to accelerating drug discovery in oncology using advanced biology and AI-powered…
Araceli Biosciences specializes in creating scientific instruments for discovering tissue- and cell-based…
VectorY utilizes a combination of antibodies and gene therapy to create effective and long-lasting treatments…
Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.
Nanopath Inc. is a company that specializes in molecular diagnostics and allows for fast, high-quality…
Frontier Bio is creating lab-grown human tissues as an ethical replacement for animal studies and is setting…
Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel…
It is our mission to open a new chapter in treating diseases and to deliver so called selectively expressed…
altM's goal is to create and produce scalable biomaterials that can assist major industries in decreasing…
The Company's corporate purpose is: I) the development of new high-value biotechnological solutions based on…
Venomics AI is a drug discovery platform using venom peptides for therapeutics.
Preventix Funding FAQs
What does Preventix do?
Preventix, created by the Mexican research laboratory Timser, is a novel screening test that uses a minimally invasive approach to detect cervical cancer early on. Rather than collecting cervical cells like the Pap smear, Preventix looks for certain biomarkers in the blood that signal inflammation or abnormalities in the cervix. By analyzing a comprehensive 53-element blood chemistry panel, the test can identify signs of inflammation or potential precancerous developments.
How much funding has Preventix raised?
Preventix has raised $3.5M across 1 round on record. The most recent is a Seed of $3.5M announced in May 2025.
When did Preventix last raise funding?
Preventix's most recent funding round on record is a Seed of $3.5M, announced in May 2025.
Who founded Preventix?
FundedIQ lists Davide Gandus (Founder) at Preventix.
Where is Preventix headquartered?
Preventix is based in Torres, Pangasinan, Philippines.
How many employees does Preventix have?
Preventix is in the 1-10 employee band.
How does Preventix's funding compare to other Biotechnology startups?
Preventix's latest round of $3.5M is below the $8.9M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.
About FundedIQ's Preventix Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Preventix is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.